Axsome Therapeutics (AXSM) News Today $108.41 +0.91 (+0.85%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$108.34 -0.06 (-0.06%) As of 05:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AXSM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Recommendation of "Buy" by Brokerages4 hours ago | marketbeat.comTrek Financial LLC Invests $3.45 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 8 at 10:16 AM | marketbeat.comPenserra Capital Management LLC Buys Shares of 19,112 Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 8 at 5:37 AM | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by Principal Financial Group Inc.July 8 at 4:13 AM | marketbeat.comAxsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21July 7 at 7:00 AM | globenewswire.comMoody Aldrich Partners LLC Has $7.27 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 4, 2025 | marketbeat.comPiper Sandler Reaffirms Price Target on Axsome (AXSM) Despite AXS-14 FDA HurdleJuly 4, 2025 | msn.comAxsome Therapeutics (NASDAQ:AXSM) Now Covered by Morgan StanleyJuly 4, 2025 | americanbankingnews.comZacks Research Issues Negative Estimate for AXSM EarningsJuly 4, 2025 | americanbankingnews.comQ2 EPS Forecast for Axsome Therapeutics Reduced by AnalystJuly 4, 2025 | americanbankingnews.comAxsome Therapeutics (NASDAQ:AXSM) Coverage Initiated at Morgan StanleyJuly 3, 2025 | marketbeat.comZacks Research Issues Pessimistic Outlook for AXSM EarningsJuly 3, 2025 | marketbeat.comZacks Research Issues Pessimistic Forecast for AXSM EarningsJuly 2, 2025 | marketbeat.comPeregrine Capital Management LLC Sells 27,466 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)July 1, 2025 | marketbeat.comLisanti Capital Growth LLC Acquires Shares of 33,280 Axsome Therapeutics, Inc. (NASDAQ:AXSM)June 29, 2025 | marketbeat.comAXSM - Axsome Therapeutics Inc Ownership - MorningstarJune 27, 2025 | morningstar.comMInsider Selling: Axsome Therapeutics, Inc. (NASDAQ:AXSM) General Counsel Sells 6,014 Shares of StockJune 24, 2025 | insidertrades.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) General Counsel Hunter R. Murdock Sells 6,014 SharesJune 23, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) General Counsel Hunter R. Murdock Sells 7,500 SharesJune 23, 2025 | marketbeat.comAxsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness MonthJune 20, 2025 | globenewswire.comHunter R. Murdock Sells 7,500 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) StockJune 19, 2025 | insidertrades.comProsperity Wealth Management Inc. Buys New Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)June 18, 2025 | marketbeat.comRBC Capital Remains a Buy on Axsome Therapeutics (AXSM)June 14, 2025 | theglobeandmail.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Given Consensus Recommendation of "Buy" by BrokeragesJune 14, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Acquired by GAMMA Investing LLCJune 13, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Price Target Cut to $186.00 by Analysts at Royal Bank of CanadaJune 12, 2025 | marketbeat.comTruist Financial Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)June 12, 2025 | theglobeandmail.comAssenagon Asset Management S.A. Grows Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)June 12, 2025 | marketbeat.comRhumbline Advisers Raises Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)June 12, 2025 | marketbeat.comAxsome Therapeutics (AXSM) Gets a Buy from Piper SandlerJune 12, 2025 | theglobeandmail.comAnalysts Conflicted on These Healthcare Names: Axsome Therapeutics (AXSM), Apellis Pharmaceuticals (APLS) and Bio-Rad Laboratories (BIO)June 12, 2025 | theglobeandmail.comOppenheimer Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)June 11, 2025 | theglobeandmail.comAxsome’s AXS-14 Gets Regulatory Setback with RTF, says Morgan StanleyJune 11, 2025 | msn.comWilliam Blair Analysts Reduce Earnings Estimates for AXSMJune 11, 2025 | marketbeat.comAxsome Therapeutics Showcases Innovation in Sleep Medicine with Multiple Presentations for AXS-12 and Solriamfetol at SLEEP 2025June 11, 2025 | globenewswire.comMark L. Jacobson Sells 25,000 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) StockJune 11, 2025 | insidertrades.comAnalysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Harrow Health (HROW)June 11, 2025 | theglobeandmail.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) COO Sells $2,761,000.00 in StockJune 10, 2025 | marketbeat.comCantor Fitzgerald Predicts AXSM FY2026 EarningsJune 10, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)June 10, 2025 | marketbeat.comAxsome shares fall after FDA issues Refusal to File letterJune 9, 2025 | investing.comAxsome fell after FDA refuses to review AXS-14 applicationJune 9, 2025 | msn.com2AXSM : Demystifying Axsome Therapeutics: Insights From 11 Analyst ReviewsJune 9, 2025 | benzinga.comAxsome Stock Slips Pre-Market After FDA Issues Refusal-To-File Letter: Retail’s Skeptical On Likelihood Of Year-End ProfitabilityJune 9, 2025 | msn.comAxsome Therapeutics (NASDAQ:AXSM) Given New $150.00 Price Target at Needham & Company LLCJune 9, 2025 | marketbeat.comPallas Capital Advisors LLC Boosts Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)June 9, 2025 | marketbeat.comAxsome Therapeutics, Inc.: Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of FibromyalgiaJune 9, 2025 | finanznachrichten.deAxsome Therapeutics Receives Refusal From FDAJune 9, 2025 | marketwatch.comAxsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of FibromyalgiaJune 9, 2025 | financialpost.comF2 Soaring Stocks Wth More Upside PotentialJune 5, 2025 | fool.com Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Email Address AXSM Media Mentions By Week AXSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXSM News Sentiment▼0.230.57▲Average Medical News Sentiment AXSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXSM Articles This Week▼1911▲AXSM Articles Average Week Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies JAZZ News TEVA News INSM News SMMT News ITCI News GMAB News RDY News MRNA News RGC News VTRS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXSM) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axsome Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AXSM Stock Alerts